Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elmiron for BCG-related LUTS in NMIBC
NCT03549650Phase 2Terminated
- Sponsor
- Jewish General Hospital
- Start
- May 2019
- Primary completion
- Feb 2022
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentosan polysulfate sodium in lower urinary tract symptoms (LUTS), sponsored by Jewish General Hospital. Started May 2019; status: terminated.
02
Drugs
pentosan polysulfate sodium
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT03549650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549650.